BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37052267)

  • 1. Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells.
    Murata T; Otsuka R; Sasaki A; Kamatani T; Wada H; Yamakawa H; Hasegawa Y; Seino KI
    Int Immunol; 2023 Jul; 35(7):327-338. PubMed ID: 37052267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell-derived hematopoietic stem and progenitor cells induce mixed chimerism and donor-specific allograft tolerance.
    Murata T; Hama N; Kamatani T; Mori A; Otsuka R; Wada H; Seino KI
    Am J Transplant; 2023 Sep; 23(9):1331-1344. PubMed ID: 37244443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model.
    Kamatani T; Otsuka R; Murata T; Wada H; Takahashi T; Mori A; Murata S; Taniguchi H; Seino KI
    Inflamm Regen; 2022 Feb; 42(1):4. PubMed ID: 35105370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for epitope spreading and active suppression in skin graft tolerance after donor-specific transfusion.
    Yang L; DuTemple B; Gorczynski RM; Levy G; Zhang L
    Transplantation; 1999 Jun; 67(11):1404-10. PubMed ID: 10385077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor-specific Transfusion.
    Zhang GY; Hu M; Watson D; Wang YM; Knight JF; Alexander SI
    Transplantation; 2020 Jul; 104(7):1385-1395. PubMed ID: 32053573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice.
    Hu Y; Zhou H; Gao B; Wang G; Wang Y
    Transpl Infect Dis; 2019 Feb; 21(1):e13012. PubMed ID: 30320937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation.
    Gagne K; Brouard S; Guillet M; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 Oct; 31(10):3111-20. PubMed ID: 11592088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
    Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft.
    Yunusov MY; Kuhr CS; Georges GE; Hogan WJ; Taranova AG; Lesnikova M; Kim YS; Abrams K; Hwang B; Sale GE; Storer B; Storb R; Nash RA
    Transplantation; 2006 Sep; 82(5):629-37. PubMed ID: 16969285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an experimental model for MHC homo-to-hetero transplantation.
    Murata T; Wada H; Otsuka R; Sasaki A; Tsuji H; Itoh M; Eguchi N; Kawai T; Seino KI
    Sci Rep; 2020 Aug; 10(1):13560. PubMed ID: 32782297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells.
    Carrier E; Lee TH; Busch MP; Cowan MJ
    Blood; 1995 Dec; 86(12):4681-90. PubMed ID: 8541562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.
    Fernandes E; Goold HD; Kissenpfennig A; Malissen B; Dyson J; Bennett CL
    Transplantation; 2011 Jan; 91(2):154-60. PubMed ID: 21085063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance and long-lasting peripheral chimerism after allogeneic intestinal transplantation in MGH miniature swine.
    Ishikawa Y; Hirakata A; Griesemer AD; Etter J; Moran S; Weiner J; Shimizu A; Yamada K
    Transplantation; 2010 Feb; 89(4):417-26. PubMed ID: 20177343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 is required for suppression of allograft rejection by donor-specific transfusion.
    Wang H; Wu X; Wang Y; Oldenborg PA; Yang YG
    J Immunol; 2010 Apr; 184(7):3401-7. PubMed ID: 20208011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.